Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Carlo Torti, Giuseppe Lapadula, Franco Maggiolo, Salvatore Casari, Fredy Suter, Lorenzo Minoli, Chiara Pezzoli, Massimo Di Pietro, Guglielmo Migliorino, Eugenia Quiros-Roldan, Nicoletta Ladisa, Laura Sighinolfi, Francesca Gatti & Giampiero Carosi. (2007) Predictors of AIDS-Defining Events Among Advanced Naïve Patients After HAART. HIV Clinical Trials 8:3, pages 112-120.
Read now
Read now
Articles from other publishers (13)
Doris Mutabazi Mwesigire, Faith Martin, Janet Seeley & Achilles Katamba. (2015) Relationship between CD4 count and quality of life over time among HIV patients in Uganda: a cohort study. Health and Quality of Life Outcomes 13:1.
Crossref
Crossref
Amanda Mocroft, Wendy P Bannister, Ole Kirk, Justyna D Kowalska, Peter Reiss, Antonella D'Arminio-Monforte, Jose Gatell, Martin Fisher, Hanna Trocha, Aza Rakhmanova & Jens D Lundgren. (2012) The Clinical Benefits of Antiretroviral Therapy in Severely Immunocompromised HIV-1-Infected Patients with and without Complete Viral Suppression. Antiviral Therapy 17:7, pages 1291-1300.
Crossref
Crossref
Xiuhong Li, Joseph B Margolick, Beth D Jamieson, Charles R Rinaldo, John P Phair & Lisa P Jacobson. (2011) CD4+ T-Cell Counts and Plasma HIV-1 RNA Levels Beyond 5 Years of Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:5, pages 421-428.
Crossref
Crossref
David R. Boulware, Katherine Huppler Hullsiek, Camille E. Puronen, Adam Rupert, Jason V. Baker, Martyn A. French, Paul R. Bohjanen, Richard M. Novak, James D. Neaton & Irini Sereti. (2011) Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death. The Journal of Infectious Diseases 203:11, pages 1637-1646.
Crossref
Crossref
Andrew M. Hill, Bonaventura Clotet, Margaret Johnson, Matthias Stoll, Nicholas Bellos & Erik Smets. (2012) Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients. PharmacoEconomics 28:S1, pages 69-81.
Crossref
Crossref
Mona R Loutfy, Miguel Genebat, David Moore, Janet Raboud, Keith Chan, Tony Antoniou, David Milan, Anya Shen, Marina B Klein, Curtis Cooper, Nima Machouf, Sean B Rourke, Anita Rachlis, Chris Tsoukas, Julio S G Montaner, Sharon L Walmsley, Marek Smieja, Ahmed Bayoumi, Edward Mills & Robert S Hogg. (2010) A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:4, pages 451-459.
Crossref
Crossref
Marlene Smurzynski, Kunling Wu, Constance A Benson, Ronald J Bosch, Ann C Collier & Susan L Koletar. (2010) Relationship Between CD4+ T-Cell Counts/HIV-1 RNA Plasma Viral Load and AIDS-Defining Events Among Persons Followed in the ACTG Longitudinal Linked Randomized Trials Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:1, pages 117-127.
Crossref
Crossref
Steven Oppenheim. (2009) Prognosis in HIV and AIDS #213. Journal of Palliative Medicine 12:9, pages 833-835.
Crossref
Crossref
Arvind Venkat, Brian Shippert, Douglas Hanneman, Chadd Nesbit, David M. Piontkowsky, Sunil Bhat & Morgen Kelly. (2008) Emergency department utilization by HIV-positive adults in the HAART era. International Journal of Emergency Medicine 1:4, pages 287-296.
Crossref
Crossref
Giuseppe Lapadula, Carlo Torti, Franco Maggiolo, Salvatore Casari, Fredy Suter, Lorenzo Minoli, Chiara Pezzoli, Massimo Di Pietro, Guglielmo Migliorino, Eugenia Quiros-Roldan, Nicoletta Ladisa, Laura Sighinolfi, Silvia Costarelli, Giampiero Carosi, G Carosi, M Puoti, C Torti, E Quiros Roldan, G Paraninfo, S Casari, A Antinori, G Antonucci, A Ammassari, A Angarano, A Saracino, R Cauda, A De Luca, A D'Arminio Monforte, P Cicconi, F Mazzotta, S Lo Caputo, N Marino, L Minoli, R Maserati, S Novati, C Tinelli, F Ghinelli, L Sighinolfi, G Pastore, N Ladisa, T Quirino, M Migliorino, F Suter, F Maggiolo, Barbara SuligoiCristina Zeni, Francesca Brognoli & Ruth Bando. (2007)
Predictors of Clinical Progression among HIV-1–Positive Patients starting HAART with CD4
+
T-cell Counts ≥200 cells/mm
3
. Antiviral Therapy 12:6, pages 941-948.
Crossref
Crossref
Rodger D MacArthur. (2007) Darunavir: promising initial results. The Lancet 369:9568, pages 1143-1144.
Crossref
Crossref
Rodger D MacArthur, Richard M Novak, Grace Peng, Li Chen, Ying Xiang, Katherine Huppler Hullsiek, Michael J Kozal, Mary van den Berg-Wolf, Christopher Henely, Barry Schmetter & Marjorie Dehlinger. (2006) A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. The Lancet 368:9553, pages 2125-2135.
Crossref
Crossref
Prabha S. Chandra, Charu Gandhi, P. Satishchandra, Anupa Kamat, Anita Desai, V. Ravi, Raymond L. Ownby, D. K. Subbakrishna & Mahendra Kumar. (2006) Quality of life in HIV subtype C infection among asymptomatic subjects and its association with CD4 counts and viral loads – a study from South India. Quality of Life Research 15:10, pages 1597-1605.
Crossref
Crossref